Gabapentin Drug Market Report – Research, Industry Analysis Reports and Market Demands

Global (United States, European Union and China) Gabapentin Drug Market Research Report 2019-2025

Request for Sample of this report

Buy now

Table of Content

1 Report Overview

1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
- 1.3.1 Global Gabapentin Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Capsule
- 1.3.3 Tablet
- 1.3.4 Oral solution
1.4 Market Segment by Application
- 1.4.1 Global Gabapentin Drug Market Share by Application (2019-2025)
- 1.4.2 Postherpetic neuralgia in adults
- 1.4.3 Partial onset seizures
- 1.4.4 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends

2.1 Global Gabapentin Drug Market Size
- 2.1.1 Global Gabapentin Drug Revenue 2014-2025
- 2.1.2 Global Gabapentin Drug Sales 2014-2025
2.2 Gabapentin Drug Growth Rate by Regions
- 2.2.1 Global Gabapentin Drug Sales by Regions 2014-2019
- 2.2.2 Global Gabapentin Drug Revenue by Regions 2014-2019
2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers

3 Market Share by Manufacturers

3.1 Gabapentin Drug Sales by Manufacturers
- 3.1.1 Gabapentin Drug Sales by Manufacturers 2014-2019
- 3.1.2 Gabapentin Drug Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
- 3.2.1 Gabapentin Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Gabapentin Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Gabapentin Drug Market Concentration Ratio (CR5 and HHI)
3.3 Gabapentin Drug Price by Manufacturers
3.4 Key Manufacturers Gabapentin Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Gabapentin Drug Market
3.6 Key Manufacturers Gabapentin Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Sales and Revenue for Each Type
- 4.1.1 Capsule Sales and Revenue (2014-2019)
- 4.1.2 Tablet Sales and Revenue (2014-2019)
- 4.1.3 Oral solution Sales and Revenue (2014-2019)
4.2 Global Gabapentin Drug Sales Market Share by Type
4.3 Global Gabapentin Drug Revenue Market Share by Type
4.4 Gabapentin Drug Price by Type

5 Market Size by Application

5.1 Overview
5.2 Global Gabapentin Drug Sales by Application

6 United States

6.1 United States Gabapentin Drug Breakdown Data by Company
6.2 United States Gabapentin Drug Breakdown Data by Type
6.3 United States Gabapentin Drug Breakdown Data by Application

7 European Union

7.1 European Union Gabapentin Drug Breakdown Data by Company
7.2 European Union Gabapentin Drug Breakdown Data by Type
7.3 European Union Gabapentin Drug Breakdown Data by Application

8 China

8.1 China Gabapentin Drug Breakdown Data by Company
8.2 China Gabapentin Drug Breakdown Data by Type
8.3 China Gabapentin Drug Breakdown Data by Application

9 Rest of World

9.1 Rest of World Gabapentin Drug Breakdown Data by Company
9.2 Rest of World Gabapentin Drug Breakdown Data by Type
9.3 Rest of World Gabapentin Drug Breakdown Data by Application
9.4 Rest of World Gabapentin Drug Breakdown Data by Countries
- 9.4.1 Rest of World Gabapentin Drug Sales by Countries
- 9.4.2 Rest of World Gabapentin Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia

10 Company Profiles

11 Value Chain and Sales Channels Analysis

11.1 Value Chain Analysis
11.2 Sales Channels Analysis
- 11.2.1 Gabapentin Drug Sales Channels
- 11.2.2 Gabapentin Drug Distributors
11.3 Gabapentin Drug Customers

12 Market Forecast

12.1 Global Gabapentin Drug Sales and Revenue Forecast 2019-2025
12.2 Global Gabapentin Drug Sales Forecast by Type
12.3 Global Gabapentin Drug Sales Forecast by Application
12.4 Gabapentin Drug Forecast by Regions
- 12.4.1 Global Gabapentin Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Gabapentin Drug Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
  - 14.1.1.1 Research Programs/Design
  - 14.1.1.2 Market Size Estimation
  - 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
  - 14.1.2.1 Secondary Sources
  - 14.1.2.2 Primary Sources
14.2 Author Details

Description

Gabapentin (sold under the brand name Neurontin, among others) is a medication which is used to treat partial seizures, neuropathic pain, hot flashes, and restless legs syndrome. It is recommended as one of a number of first-line medications for the treatment of neuropathic pain caused by diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. About 15% of those given gabapentin for diabetic neuropathy or postherpetic neuralgia have a measurable benefit. Gabapentin is taken by mouth.
In 2019, the market size of Gabapentin Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Gabapentin Drug.

This report studies the global market size of Gabapentin Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Gabapentin Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Pfizer
Depomed
Apotex
Teva
Acella Pharmaceuticals
Taro
Sun Pharmaceutical
Glenmark
Amneal Pharmaceuticals
Aurobindo Pharma
Zydus Pharmaceuticals
Hi-Tech Pharmaceuticals
Marksans Pharma
Mylan
InvaGen Pharmaceuticals
Alkem Laboratories
Tris Pharma
ACI HealthCare Limited
Jiangsu Hengrui Medicine
CSPC Ouyi Pharmaceutical
Sciegen Pharmaceuticals
Epic Pharma
Lupin Limited

Market Segment by Product Type
Capsule
Tablet
Oral solution

Market Segment by Application
Postherpetic neuralgia in adults
Partial onset seizures
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Gabapentin Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Gabapentin Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Gabapentin Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025